Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Hyponatremia and Rehabilitation Outcomes After Stroke: A Single-Center Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Quantum transduction from electron spin state to a signaling state in a wild-type LOV photoreceptor.

bioRxiv : the preprint server for biology·2026
Same author

A wireless subdural-contained brain-computer interface with 65,536 electrodes and 1,024 channels.

Nature electronics·2026
Same author

High-Throughput Screening Identifies Small-Molecule Inhibitors of the Tau-LRP1 Interaction.

bioRxiv : the preprint server for biology·2026
Same author

Charge Dependence of Local Hydration Dynamics in Poly(Acrylic Acid) Solutions.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Context-Aware Hydrophobicity Modeling: HydroMap and FastHydroMap.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 29, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.6K

Precision proteoform design for 4R tau isoform selective templated aggregation.

Andrew P Longhini1,2, Austin DuBose3, Samuel Lobo4

  • 1Neuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA 93106.

Proceedings of the National Academy of Sciences of the United States of America
|April 3, 2024
PubMed
Summary

Prion-like tau fibrils propagate 4R tau aggregation, not 3R tau. Molecular dynamics revealed a unique U-fold in 4R tau seeding, enabling isoform-specific therapeutic strategies for tauopathies.

Keywords:
amyloidogenic coreprion-like templatingprotein misfoldingtauopathies

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.8K

Related Experiment Videos

Last Updated: Jun 29, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.6K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.4K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.8K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Prion-like spread of tau conformers is characteristic of tauopathies.
  • Tauopathies involve the aggregation of tau protein, a key component of microtubules.

Purpose of the Study:

  • To investigate the structural basis of tau fibril seeding and propagation.
  • To explore the differential seeding activity between 4R and 3R tau isoforms.
  • To identify potential therapeutic targets for tauopathies.

Main Methods:

  • A 19-residue tau peptide probe with a P301L mutation was synthesized.
  • Fibril formation and seeding assays were performed.
  • Fully atomistic replica exchange molecular dynamics (MD) simulations were employed.
  • Conformational analysis and isoform-specific mutation studies were conducted.

Main Results:

  • The tau peptide formed seeding-competent fibrils with a high β-sheet content and a U-shaped fold specific to 4R tauopathy.
  • These fibrils induced aggregation of 4R tau but not 3R tau.
  • MD simulations identified an aggregation-competent U-fold and an aggregation-prohibiting β-hairpin structure.
  • Specific amino acid substitutions modulated the seeding activity, demonstrating isoform specificity.

Conclusions:

  • Tau peptide fibrils act as templates for 4R tau propagation, functioning as partial prions.
  • The unique U-fold in 4R tau fibrils is critical for seeding and propagation.
  • Findings suggest opportunities for tau isoform-specific therapeutic interventions in tauopathies.